TD Waterhouse Canada Inc. Sells 20,547 Shares of Oscar Health, Inc. $OSCR

TD Waterhouse Canada Inc. lessened its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 64.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,443 shares of the company’s stock after selling 20,547 shares during the period. TD Waterhouse Canada Inc.’s holdings in Oscar Health were worth $326,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new position in Oscar Health during the 1st quarter valued at $30,000. CoreCap Advisors LLC grew its position in Oscar Health by 526.3% in the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after acquiring an additional 1,000 shares during the last quarter. Quarry LP grew its position in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after purchasing an additional 357 shares during the period. Institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on OSCR. Wells Fargo & Company lifted their target price on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. Piper Sandler restated an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a report on Tuesday, July 28th. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a research note on Friday, August 7th. UBS Group lifted their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Finally, Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $26.22.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Janet Liang sold 10,360 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $325,822.00. Following the transaction, the insider owned 248,697 shares of the company’s stock, valued at approximately $7,821,520.65. This trade represents a 4.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 31,422 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $988,221.90. Following the completion of the sale, the director owned 449,444 shares of the company’s stock, valued at approximately $14,135,013.80. This represents a 6.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 4,322,257 shares of company stock valued at $126,818,346 over the last three months. 22.64% of the stock is currently owned by corporate insiders.

Oscar Health Trading Up 0.4%

Shares of NYSE OSCR opened at $32.70 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The business has a fifty day simple moving average of $30.60 and a two-hundred day simple moving average of $23.34. The firm has a market cap of $10.09 billion, a PE ratio of 23.36, a price-to-earnings-growth ratio of 0.67 and a beta of 2.37. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $34.23.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.73 billion. During the same period in the prior year, the business earned ($0.89) EPS. The business’s revenue for the quarter was up 70.4% compared to the same quarter last year. Analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.